Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
Osteoporos Int. 2018 May;29(5):1057-1067. doi: 10.1007/s00198-018-4384-1. Epub 2018 Feb 14.
This study investigated the relationship between muscle and bone status in elderly individuals. Our results suggested links between sarcopenia and osteoporosis; impairment in muscle status (i.e., muscle mass, muscle strength, and physical performance) is associated with deterioration in bone mass and texture subsequently leading to an increased risk of fracture.
Accumulating evidence has shown associations between sarcopenia and osteoporosis, but existing studies face inconsistencies in the clinical definition of both conditions. Thus, we sought to investigate bone health among older individuals with or without muscle health impairment.
We conducted an analysis of cross-sectional data available from the Sarcopenia and Physical Impairment with Advancing Age (SarcoPhAge) study. Sarcopenia was diagnosed according to the European Working Group on Sarcopenia in Older People (EWGSOP) (i.e., a low muscle mass plus either low muscle strength or low physical performance). Muscle mass and areal bone mineral density (aBMD) were determined using dual-energy X-ray absorptiometry (DEXA). Muscle strength was assessed using a hand dynamometer, and physical performance was assessed with the Short Physical Performance Battery test. Using the cutoff limits proposed by the EWGSOP, we have classified women in the "low SMI group" when its value was < 5.50 kg/m, in the "low muscle strength group" when strength was < 20 kg, and in the "low physical performance group" when SPPB < 8 points. The thresholds of < 7.26 kg/m (for SMI), < 30 kg (for muscle strength), and SPPB < 8 points were used for men. The 10-year fracture risk was obtained using the FRAX® tool. Moreover, bone texture was determined using the trabecular bone score (TBS) method.
The study sample consisted of 288 older subjects aged 74.7 ± 5.7 years, and 59.0% of the subjects were women. Sarcopenia was diagnosed in 43 individuals (14.9%), and osteoporosis was diagnosed in 36 subjects (12.5%). Moreover, aBMD values were, most of the time, lower in older men and women with muscle impairment (i.e., low muscle mass, low muscle strength, and low physical performance). For these subjects, we also noted a higher probability of fracture. When comparing bone quality, there were no significant differences in the TBS values between sarcopenic and non-sarcopenic older men and women or between those with low and high muscle mass. However, when controlling for confounders (i.e., age, BMI, number of co-morbidities, smoking status, and nutritional status), TBS values were lower in older women with low muscle strength (p = 0.04) and in older men with low physical performance (p = 0.01).
Our study showed interrelationships between components of sarcopenia and osteoporosis, with older subjects with muscle impairment having poorer bone health.
本研究旨在探讨老年人肌肉和骨骼状况之间的关系。我们的研究结果表明,肌肉减少症与骨质疏松症之间存在关联;肌肉状况(即肌肉质量、肌肉力量和身体机能)的损害与骨量和骨质量的恶化有关,进而增加了骨折的风险。
我们对来自肌肉减少症和身体功能障碍与老龄化(SarcoPhAge)研究的横断面数据进行了分析。根据欧洲肌肉减少症工作组(EWGSOP)的标准诊断肌肉减少症(即低肌肉质量加上低肌肉力量或低身体机能)。使用双能 X 射线吸收法(DEXA)测定肌肉质量和骨矿物质密度(aBMD)。使用握力计评估肌肉力量,使用短体物理表现电池测试(SPPB)评估身体机能。根据 EWGSOP 提出的截断值,当女性的体质量指数(SMI)值<5.50 kg/m 时,将其归为“低 SMI 组”;当女性的肌肉力量<20 kg 时,将其归为“低肌肉力量组”;当女性的 SPPB<8 分,则将其归为“低身体机能组”。对于男性,使用<7.26 kg/m(用于 SMI)、<30 kg(用于肌肉力量)和 SPPB<8 分作为截断值。使用 FRAX®工具获得 10 年骨折风险。此外,使用骨小梁评分(TBS)方法确定骨纹理。
研究样本包括 288 名年龄 74.7±5.7 岁的老年人,其中 59.0%为女性。43 名(14.9%)被诊断为肌肉减少症,36 名(12.5%)被诊断为骨质疏松症。此外,肌肉功能受损(即低肌肉质量、低肌肉力量和低身体机能)的老年男性和女性的 aBMD 值往往较低。对于这些患者,我们还发现骨折的概率更高。在比较骨质量时,肌肉减少症和非肌肉减少症的老年男性和女性或肌肉质量低和高的患者之间的 TBS 值没有显著差异。然而,在控制混杂因素(即年龄、BMI、共病数量、吸烟状况和营养状况)后,低肌肉力量的老年女性(p=0.04)和低身体机能的老年男性(p=0.01)的 TBS 值较低。
我们的研究表明,肌肉减少症的各组成部分与骨质疏松症之间存在相互关系,肌肉功能受损的老年患者骨骼健康状况较差。